APA

Aurer I., Duraković N., Radman I., Nemet D., Zupancić-Salek S., Kovacević-Metelko J., Bogdanić V., Sertić D., Mrsić M., Mikulić M. & Labar B. (20021224). Combination of ifosfamide, methotrexate, and etoposide (IMVP) as a salvage therapy for relapsed and refractory aggressive non-Hodgkin lymphoma: retrospective study. : Croatian medical journal.

Chicago

Aurer Igor, Duraković Nadira, Radman Ivo, Nemet Damir, Zupancić-Salek Silva, Kovacević-Metelko Jasminka, Bogdanić Vinko, Sertić Dubravka, Mrsić Mirando, Mikulić Mirta and Labar Boris. 20021224. Combination of ifosfamide, methotrexate, and etoposide (IMVP) as a salvage therapy for relapsed and refractory aggressive non-Hodgkin lymphoma: retrospective study. : Croatian medical journal.

Harvard

Aurer I., Duraković N., Radman I., Nemet D., Zupancić-Salek S., Kovacević-Metelko J., Bogdanić V., Sertić D., Mrsić M., Mikulić M. and Labar B. (20021224). Combination of ifosfamide, methotrexate, and etoposide (IMVP) as a salvage therapy for relapsed and refractory aggressive non-Hodgkin lymphoma: retrospective study. : Croatian medical journal.

MLA

Aurer Igor, Duraković Nadira, Radman Ivo, Nemet Damir, Zupancić-Salek Silva, Kovacević-Metelko Jasminka, Bogdanić Vinko, Sertić Dubravka, Mrsić Mirando, Mikulić Mirta and Labar Boris. Combination of ifosfamide, methotrexate, and etoposide (IMVP) as a salvage therapy for relapsed and refractory aggressive non-Hodgkin lymphoma: retrospective study. : Croatian medical journal. 20021224.